Qube Research & Technologies (QRT)
RXRX icon

Qube Research & Technologies (QRT)’s Recursion Pharmaceuticals RXRX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-172,349
Closed -$912K – 3910
2025
Q1 		$912K Buy
+172,349
New +$1.26M ﹤0.01% 2315

Other funds holding RXRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
KA
Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return

Qube Research & Technologies (QRT)'s RXRX Position: Q2 2025 in Review

Qube Research & Technologies (QRT) sold out of Recursion Pharmaceuticals (RXRX) in Q2 2025, closing a stake of 172,349 shares — an estimated $912K sold.

Qube Research & Technologies (QRT) first reported a position in RXRX in Q1 2025 and held it in 1 quarter. The position peaked at $912K in Q1 2025. 332 funds tracked by Wall St. Rank hold RXRX as of Q2 2025.

  • Qube Research & Technologies (QRT) reported no remaining Recursion Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 172,349 Recursion Pharmaceuticals shares in Q2 2025, an estimated $912K.
  • Qube Research & Technologies (QRT) first reported a position in Recursion Pharmaceuticals in Q1 2025 and held it in 1 quarter.
  • Qube Research & Technologies (QRT)'s Recursion Pharmaceuticals position peaked at $912K in Q1 2025.
  • 332 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q2 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2025, filed 14 Aug 2025.